Procyon


Procyon 's P3000 Pro is the first pupillometer seeking FDA labelling for Glaucoma screening. Feasibility studies under the auspices of Moorfields Eye Hospital demonstrated a 87% sensitivity and specificity for Glaucoma, a significant statistical improvement in accuracy over current technology. The Procyon management team has extensive experience in ophthalmic devices - research/development, FDA trials, Medicare, marketing/sales.
View Top Employees for Procyon
img Industry Computer Software
img Location United States
img Employees 56
img Industry Computer Software
img Location United States
img Employees 56
img LinkedIn linkedin.com/company/procyon